Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo

柯里拉京通过抑制OLFR2信号通路介导的NLRP3炎症小体活化，在体外和体内均能缓解动脉粥样硬化。